Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale and Clinical Development of Aramchol(TM) for NASH

Press/Media

Period16 Apr 2018

Media coverage

1

Media coverage

  • TitleGalmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale and Clinical Development of Aramchol(TM) for NASH
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date16/04/18
    PersonsLynn Friedman, Scott Friedman